Le Lézard
Classified in: Health
Subject: SHM

Numinus Announces Cancellation and Rescheduling of Annual General Meeting of Shareholders


VANCOUVER, BC, Jan. 13, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, announced today that its annual general meeting of shareholders (the "AGM"), which was originally scheduled to be held on Friday, January 21, 2022, has been cancelled and rescheduled to be held on February 28, 2022. The Company's Board of Directors determined that it would be in the best interests of the Company to reschedule the AGM for a variety of reasons, including a change to at least one resolution.

Further details on the AGM will be contained in a new Notice of Meeting and Management Information Circular that will be mailed to shareholders of the Company and filed on SEDAR.

About Numinus
Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model ? including psychedelic production, research and clinic care ? is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society. 

Learn more at www.numinus.com and follow us on LinkedInFacebookTwitter, and Instagram.

Forward-Looking Statements
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.

SOURCE Numinus Wellness Inc.


These press releases may also interest you

at 12:07
Pet parents may fear their pets' aging ? because "growing old" is associated with slowing down and losing some of the spirit and vibrancy that makes them special. That's why Hill's Pet Nutrition (Hill's) is teaming up with actress and senior pet...

at 12:00
The American Society for Gastroenterology and Endoscopy (ASGE) announced today the launch of the Artificial Intelligence Institute for Gastroenterology, a milestone initiative to integrate artificial intelligence (AI) into gastrointestinal (GI) care,...

at 12:00
Healthly, a future-forward healthcare organization, is pleased to announce Wayne Dysinger, M.D., Master of Public Health (MPH), Diplomate of the American Board of Lifestyle Medicine (ABLM), Fellow and Past President of the American College of...

at 12:00
As You Are, the nation's leading telehealth provider of pediatric autism evaluations, announces a collaboration with Included Health, a new kind of healthcare company delivering virtual care and navigation for millions of people nationwide....

at 12:00
Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed, announced today that the U.S....

at 12:00
In anticipation of commercial launch of the AlphaION Point of Care diagnostic platform, Center Point Bio-Tech, LLC ("CP Bio") entered into a non-exclusive distribution agreement with a well-known and highly respected veterinary distributor...



News published on and distributed by: